Peter Scardino, MD, Urology, New York, NY, Memorial Sloan-Kettering Cancer Center

PeterTScardinoMDFACS

Urology New York, NY

David H. Koch Chair, Attending Urologist, Dept. of Surgery

Dr. Scardino is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Scardino's full profile

Already have an account?

  • Office

    Memorial Sloan Kettering Cancer Center
    Kimmel Center for Prostate and Urologic Cancer, 353 E. 68th St
    New York, NY 10065
    Phone(646) 422-4329
    Fax(646) 422-1095
  • Is this information wrong?

Education & Training

  • UCLA Medical Center
    UCLA Medical CenterResidency, Urology, 1979
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Surgical Oncology, 1976
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, General Surgery, 1971 - 1973
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1971

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1998 - 2023
  • TX State Medical License
    TX State Medical License 1979 - 2000
  • CA State Medical License
    CA State Medical License 1975 - Present
  • MD State Medical License
    MD State Medical License 1973 - 1983
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Ramon Guteras Award American Urological Association, 2014
  • Fellow (FACS) American College of Surgeons
  • Barringer Medal American Association of Genitourinary Surgeons, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-S...  
    John P Mulhall, Eric A Klein, Kevin Slawin, Peter T Scardino, The Journal of Sexual Medicine

Authored Content

  • Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018
  • Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018

Press Mentions

  • 20-Year Follow-up Data Are in: Prostate Cancer Prevention Works; Concerns About High-Grade Disease Dismissed
    20-Year Follow-up Data Are in: Prostate Cancer Prevention Works; Concerns About High-Grade Disease DismissedFebruary 1st, 2019
  • Better Survival Outcomes for Advanced Prostate Cancer Patients Treated with Surgery Followed by Radiation Than with Radiation plus Hormone Therapy
    Better Survival Outcomes for Advanced Prostate Cancer Patients Treated with Surgery Followed by Radiation Than with Radiation plus Hormone TherapySeptember 20th, 2018
  • Shop Talk
    Shop TalkMarch 25th, 2017
  • Join now to see all

Grant Support

  • Urologic Oncology Research Training GrantNational Cancer Institute2005–2011
  • Developmental Research ProgramNational Cancer Institute2006–2010
  • Career Development ProgramNational Cancer Institute2006–2010
  • Spore In Prostate CancerNational Cancer Institute2001–2008
  • Urology Oncology Research Training GrantNational Cancer Institute1999–2003
  • Antenoviral Vector Delivery Of HSK TK Gene With Gancivlovir In Prostate CancerNational Center For Research Resources1998–2001
  • Markers Of Progression And MetastasesNational Cancer Institute1996–2001
  • Prostate Neoplasm--Developmental ProjectsNational Cancer Institute1992–2001
  • Prostate Neoplasm--Career Development ProgramNational Cancer Institute1992–2001
  • Spore In Prostate CancerNational Cancer Institute1996–1997
  • Specialized PGM Of Research Excellence/Prostate CancerNational Cancer Institute1992–1995
  • DNA Ploidy And Molecular Markers Of Prostate CancerNational Cancer Institute1992–1995
  • Transrectal Ultrasonography For Prostate CancerNational Cancer Institute1988–1992
  • Chemotherapy Trials For Carcinoma Of The ProstateNational Cancer Institute1985

Professional Memberships

Hospital Affiliations